BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 16876392)

  • 1. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
    Fuertes I; Miranda A; Millán M; Caraballo I
    Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of percolation theory in the study of an extended release Verapamil hydrochloride formulation.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    Int J Pharm; 2008 Sep; 361(1-2):112-7. PubMed ID: 18621491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of critical points of drugs with different solubilities in hydrophilic matrices.
    Fuertes I; Caraballo I; Miranda A; Millán M
    Int J Pharm; 2010 Jan; 383(1-2):138-46. PubMed ID: 19766706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets.
    Aguilar-de-Leyva A; Cifuentes C; Rajabi-Siahboomi AR; Caraballo I
    Eur J Pharm Biopharm; 2012 Jan; 80(1):136-42. PubMed ID: 21946473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Chem Pharm Bull (Tokyo); 2006 May; 54(5):598-602. PubMed ID: 16651752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets.
    Gil EC; Colarte AI; Bataille B; Caraballo I
    AAPS PharmSciTech; 2007 Dec; 8(4):E115. PubMed ID: 18181536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the critical points of experimental HPMC-NaCMC hydrophilic matrices.
    Contreras L; Melgoza LM; Villalobos R; Caraballo I
    Int J Pharm; 2010 Feb; 386(1-2):52-60. PubMed ID: 19900524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the percolation thresholds in ternary lobenzarit disodium-dextran-HPMC hydrophilic matrices tablets: effects of initial porosity.
    Castellanos Gil E; Iraizoz Colarte A; Bataille B; Brouillet F; Caraballo I
    Eur J Pharm Sci; 2009 Nov; 38(4):312-9. PubMed ID: 19666114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer percolation threshold in HPMC extended release formulation of carbamazepine and verapamil HCl.
    Gonçalves-Araújo T; Rajabi-Siahboomi AR; Caraballo I
    AAPS PharmSciTech; 2010 Jun; 11(2):558-62. PubMed ID: 20352536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2010 Mar; 387(1-2):56-64. PubMed ID: 19969052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
    Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
    Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer Percolation Threshold in Multi-Component HPMC Matrices Tablets.
    Maghsoodi M; Barghi L
    Adv Pharm Bull; 2011; 1(1):27-33. PubMed ID: 24312753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2008 Mar; 351(1-2):61-73. PubMed ID: 17996408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
    Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release polymeric ocular delivery of acyclovir.
    Deshpande PB; Dandagi P; Udupa N; Gopal SV; Jain SS; Vasanth SG
    Pharm Dev Technol; 2010; 15(4):369-78. PubMed ID: 19772377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories.
    Caraballo I
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1291-301. PubMed ID: 20977292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.